Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-210"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20101124.15.3-210"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"There are many sources of independent and evidence-based information on treatment options available within the European Union. These resources take into account cultural specificities and contexts for the population, including health determinants. Increased access to quality information will help achieve better health outcomes for patients as better informed patients are much more likely to continue necessary treatments and have far more chance of understanding the decisions related to their treatment. Consequently, if properly phrased and implemented, the proposal will generate added value.
The regulation being discussed fails to take into account technical developments, as well as the opportunities and challenges created by the Internet. Patients in Europe already have unlimited access via the Internet to uncontrolled and frequently incorrect information about prescription-only medicines in a few seconds. However, access via the Internet to controlled and safe drug information is very limited for most patients. This is especially a problem for those who need information in their own language. Therefore, the objective of the proposal can not only be to harmonise European legislation but also to improve health through improved health-related knowledge."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples